Rabbit Polyclonal TRAIL antibody. Suitable for WB, IHC-P and reacts with Recombinant full length protein - Mouse, Mouse, Human samples. Cited in 8 publications. Immunogen corresponding to Recombinant Fragment Protein within Mouse Tnfsf10 aa 1 to C-terminus.
View Alternative Names
CD253, APO2L, TRAIL, TNFSF10, Tumor necrosis factor ligand superfamily member 10, Apo-2 ligand, TNF-related apoptosis-inducing ligand, Apo-2L, Protein TRAIL
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRAIL antibody (AB231265)
Formalin-fixed, paraffin-embedded mouse kidney tissue stained for TRAIL with ab231265 at 20 μg/ml in immunohistochemical analysis. DAB staining.
- WB
Supplier Data
Western blot - Anti-TRAIL antibody (AB231265)
All lanes:
Western blot - Anti-TRAIL antibody (ab231265) at 2 µg/mL
All lanes:
A549 (Human lung carcinoma cell line) cell lysate
Predicted band size: 32 kDa
false
- WB
Supplier Data
Western blot - Anti-TRAIL antibody (AB231265)
All lanes:
Western blot - Anti-TRAIL antibody (ab231265) at 2 µg/mL
All lanes:
Recombinant mouse TRAIL protein
Predicted band size: 32 kDa,55 kDa
false
- WB
Supplier Data
Western blot - Anti-TRAIL antibody (AB231265)
All lanes:
Western blot - Anti-TRAIL antibody (ab231265) at 2 µg/mL
All lanes:
MCF7 (Human breast adenocarcinoma cell line) cell lysate
Predicted band size: 32 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TRAIL's function extends beyond inducing cell death. It is an important member of the tumor necrosis factor (TNF) superfamily which regulates immune responses and inflammation. TRAIL can form a homotrimeric complex allowing it to bind effectively to death receptors on target cells specifically DR4 and DR5 triggering a series of downstream signaling events. This interaction is significant in modulating immune surveillance and tumor suppression.
Pathways
TRAIL is integral to both intrinsic and extrinsic apoptosis pathways. Through these pathways TRAIL is closely related to FADD and caspase-8 which are important for apoptosis induction. The extrinsic pathway involves binding to TRAIL death receptors leading to DISC formation while the intrinsic pathway involves mitochondrial events mediated by members of the Bcl-2 protein family.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 20:15 PubMed39918606
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cellular and molecular gastroenterology and hepatology 17:853-876 PubMed38219900
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 12:20380-20395 PubMed37843231
2023
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 14:1171293 PubMed37274104
2023
Applications
Unspecified application
Species
Unspecified reactive species
Biomolecules 13: PubMed37238701
2023
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of clinical investigation 132: PubMed36136587
2022
Applications
Unspecified application
Species
Unspecified reactive species
American journal of cancer research 12:2118-2131 PubMed35693092
2022
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular physiology 235:2676-2686 PubMed31508816
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com